Latest Sio Capital Management, LLC Stock Portfolio
Sio Capital Management, LLC Performance:
2024 Q3: 5%YTD: 3.58%2023: -4.95%
Performance for 2024 Q3 is 5%, and YTD is 3.58%, and 2023 is -4.95%.
About Sio Capital Management, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Sio Capital Management, LLC reported an equity portfolio of $252.2 Millions as of 30 Sep, 2024.
The top stock holdings of Sio Capital Management, LLC are , TEVA, MMS. The fund has invested 15.4% of it's portfolio in LABCORP HOLDINGS INC and 9.6% of portfolio in TEVA PHARMACEUTICAL INDUSTRIES LTD.
The fund managers got completely rid off SMITH & NEPHEW PLC, ORGANON & CO (OGN) and CORBUS PHARMACEUTICALS HLDGS (CRBP) stocks. They significantly reduced their stock positions in MODULAR MED INC (MODD), TELEFLEX INCORPORATED (TFX) and X4 PHARMACEUTICALS INC (XFOR). Sio Capital Management, LLC opened new stock positions in TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), MAXIMUS INC (MMS) and ANNEXON INC (ANNX). The fund showed a lot of confidence in some stocks as they added substantially to COMPASS PATHWAYS PLC (CMPS), VENTYX BIOSCIENCES INC (VTYX) and PMV PHARMACEUTICALS INC (PMVP).
The top stock holdings of Sio Capital Management, LLC are , TEVA, MMS. The fund has invested 15.4% of it's portfolio in LABCORP HOLDINGS INC and 9.6% of portfolio in TEVA PHARMACEUTICAL INDUSTRIES LTD.
The fund managers got completely rid off SMITH & NEPHEW PLC, ORGANON & CO (OGN) and CORBUS PHARMACEUTICALS HLDGS (CRBP) stocks. They significantly reduced their stock positions in MODULAR MED INC (MODD), TELEFLEX INCORPORATED (TFX) and X4 PHARMACEUTICALS INC (XFOR). Sio Capital Management, LLC opened new stock positions in TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), MAXIMUS INC (MMS) and ANNEXON INC (ANNX). The fund showed a lot of confidence in some stocks as they added substantially to COMPASS PATHWAYS PLC (CMPS), VENTYX BIOSCIENCES INC (VTYX) and PMV PHARMACEUTICALS INC (PMVP).
Sio Capital Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Sio Capital Management, LLC made a return of 5% in the last quarter. In trailing 12 months, it's portfolio return was 12.88%.
New Buys
| Ticker | $ Bought |
|---|---|
| teva pharmaceutical industries ltd | 24,313,900 |
| maximus inc | 14,453,000 |
| annexon inc | 8,484,280 |
| relay therapeutics inc | 6,696,540 |
| ideaya biosciences inc | 3,896,640 |
| artivion inc | 3,225,760 |
| cargo therapeutics inc | 3,207,720 |
| terns pharmaceuticals inc | 83,400 |
New stocks bought by Sio Capital Management, LLC
Additions
| Ticker | % Inc. |
|---|---|
| compass pathways plc | 211 |
| ventyx biosciences inc | 153 |
| pmv pharmaceuticals inc | 18.68 |
Additions to existing portfolio by Sio Capital Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| modular med inc | -92.15 |
| teleflex incorporated | -64.64 |
| x4 pharmaceuticals inc | -47.86 |
| tyra biosciences inc | -33.22 |
| labcorp holdings inc | -29.53 |
| erasca inc | -22.8 |
| zimmer biomet holdings inc | -17.9 |
| vaxart inc | -7.83 |
Sio Capital Management, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| organon & co | -12,587,600 |
| smith & nephew plc | -14,363,000 |
| zymeworks inc | -4,179,500 |
| prelude therapeutics inc | -1,220,700 |
| gsk plc | -12,012,000 |
| bausch plus lomb corp | -4,395,350 |
| aslan pharmaceuticals ltd | -76,245 |
| corbus pharmaceuticals hldgs | -10,188,700 |
Sio Capital Management, LLC got rid off the above stocks
Sector Distribution
Sio Capital Management, LLC has about 65.2% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 65.2 |
| Others | 28.3 |
| Industrials | 6.5 |
Market Cap. Distribution
Sio Capital Management, LLC has about 25.5% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 28.3 |
| LARGE-CAP | 25.5 |
| SMALL-CAP | 21 |
| MICRO-CAP | 16.1 |
| MID-CAP | 8.2 |
Stocks belong to which Index?
About 47.3% of the stocks held by Sio Capital Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 52.6 |
| RUSSELL 2000 | 32.7 |
| S&P 500 | 14.6 |
Sio Capital Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Sio Capital Management, LLC
Sio Capital Management, LLC has 38 stocks in it's portfolio. About 60% of the portfolio is in top 10 stocks. IDYA proved to be the most loss making stock for the portfolio. TYRA was the most profitable stock for Sio Capital Management, LLC last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABT | abbott laboratories | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ANIP | ani pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ANNX | annexon inc | 3.36 | 1,433,160 | 8,484,280 | new | |||
| AORT | artivion inc | 1.28 | 121,178 | 3,225,760 | new | |||
| APRE | aprea therapeutics inc | 0.30 | 276,603 | 760,658 | unchanged | 0.00 | ||
| ARQT | arcutis biotherapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ASLN | aslan pharmaceuticals ltd | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ATXS | astria therapeutics inc | 2.20 | 504,887 | 5,558,810 | reduced | -1.05 | ||
| AVTX | avalo therapeutics inc | 0.27 | 71,458 | 678,851 | unchanged | 0.00 | ||
| BBIO | bridgebio pharma inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BDSX | biodesix inc | 3.06 | 4,338,510 | 7,722,560 | reduced | -0.21 | ||
| BLCO | bausch plus lomb corp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CI | the cigna group | 3.64 | 26,503 | 9,181,700 | reduced | -1.06 | ||
| CMAX | caremax inc | 0.00 | 12,808 | 108 | unchanged | 0.00 | ||
| CMPS | compass pathways plc | 2.29 | 914,639 | 5,762,230 | added | 211 | ||
| CNTX | context therapeutics inc | 1.03 | 1,328,350 | 2,603,570 | unchanged | 0.00 | ||
| CRBP | corbus pharmaceuticals hldgs | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ENTA | enanta pharmaceuticals inc | 0.73 | 177,004 | 1,833,760 | unchanged | 0.00 | ||
| ERAS | erasca inc | 2.40 | 2,219,190 | 6,058,380 | reduced | -22.8 | ||
| FHTX | foghorn therapeutics inc. | 0.45 | 121,672 | 1,132,770 | unchanged | 0.00 | ||